Oncocin (1-11)-MDAP-2 (28-35)[R15r,Q19r]

General Information


DRACP ID  DRACP04088

Peptide Name   Oncocin (1-11)-MDAP-2 (28-35)[R15r,Q19r]

Sequence  VDKPPYLPRPRPIRrPGGr

Sequence Length  19

UniProt ID  A0A088N522 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  PEG 5000

C-terminal Modification  Amidation

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C88H139N27O19

Absent amino acids  ACEFHMNQSTW

Common amino acids  P

Mass  220046

Pl  11.43

Basic residues  4

Acidic residues  1

Hydrophobic residues  3

Net charge  3

Boman Index  -4341

Hydrophobicity  -105.79

Aliphatic Index  56.32

Half Life 
  /

Extinction Coefficient cystines  1490

Absorbance 280nm  82.78

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33129837

Title  Preparation, Characterization and Pharmacokinetic Study of N-Terminal PEGylated D-Form Antimicrobial Peptide OM19r-8

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  16950

DRACP is developed by Dr.Zheng's team.